Mexico - Delayed Quote MXN

Eli Lilly and Company (LLY.MX)

14,400.00
-413.00
(-2.79%)
At close: May 9 at 1:44:50 PM CST

Research Analysis

Revenue vs. Earnings

Revenue 12.73B
Earnings 3B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 16152626
Avg. Estimate 14.32B15.37B59.61B71.36B
Low Estimate 13.96B14.8B58.31B65.07B
High Estimate 14.85B15.95B62.38B79.04B
Year Ago Sales 11.3B11.44B45.04B59.61B
Sales Growth (year/est) 26.73%34.38%32.34%19.70%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LLY.MX --------
S&P 500 13.21%3.06%8.01%13.77%

Upgrades & Downgrades

Maintains UBS: Buy to Buy 5/2/2025
Downgrade HSBC: Buy to Reduce 4/28/2025
Initiated Cantor Fitzgerald: Overweight 4/22/2025
Maintains Guggenheim: Buy to Buy 4/14/2025
Maintains Morgan Stanley: Overweight to Overweight 4/9/2025
Upgrade Goldman Sachs: Neutral to Buy 4/8/2025

Related Tickers